<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>OnSight Pathology: A real-time platform-agnostic computational pathology companion for histopathology - Health AI Hub</title>
    <meta name="description" content="OnSight Pathology introduces a novel platform-agnostic computer vision software designed to integrate real-time artificial intelligence (AI) inferences directly">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>OnSight Pathology: A real-time platform-agnostic computational pathology companion for histopathology</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2512.04187v1" target="_blank">2512.04187v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-12-03
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Jinzhen Hu, Kevin Faust, Parsa Babaei Zadeh, Adrienn Bourkas, Shane Eaton, Andrew Young, Anzar Alvi, Dimitrios George Oreopoulos, Ameesha Paliwal, Assem Saleh Alrumeh, Evelyn Rose Kamski-Hennekam, Phedias Diamandis
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.CV, cs.AI
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.95 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2512.04187v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2512.04187v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">OnSight Pathology introduces a novel platform-agnostic computer vision software designed to integrate real-time artificial intelligence (AI) inferences directly into existing histopathology workflows. By utilizing continuous screen captures, this self-contained executable operates locally on consumer-grade personal computers, overcoming barriers related to proprietary digital pathology solutions and complex IT integration to democratize AI adoption in diagnostic pathology.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This platform significantly advances medical diagnostics by democratizing access to AI-powered histological analysis, enhancing diagnostic accuracy, standardizing interpretations, and extending expert capabilities to resource-limited or remote clinical environments, ultimately improving patient care pathways.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The AI application is a real-time, platform-agnostic computational pathology companion that assists pathologists in reviewing digital slide images. It uses computer vision to provide AI inferences for critical medical diagnostic tasks such as classifying brain tumor types, detecting mitosis for tumor grading, and quantifying immunohistochemical stains. This aims to improve the accuracy, efficiency, and accessibility of disease classification and diagnosis in clinical and research pathology workflows, including inter-operative and telepathology settings.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>**Platform-Agnostic Design:** Utilizes continuous custom screen captures to provide real-time AI inferences, making it compatible with any digital slide viewer or even live microscope feeds.</li>
                    
                    <li>**Accessible & Secure Deployment:** Distributed as a single, self-contained executable file, it operates locally on consumer-grade PCs without complex software integration, ensuring cost-effectiveness and data security.</li>
                    
                    <li>**Broad Utility Demonstration:** Validated using over 2,500 publicly available whole slide images (WSIs) across diverse slide viewers, as well as cases from clinical digital pathology setups.</li>
                    
                    <li>**Robust Performance on Key Tasks:** Demonstrated effectiveness in routine histopathological tasks, including the classification of common brain tumor types, detection of mitosis, and quantification of immunohistochemical (IHC) stains.</li>
                    
                    <li>**Integrated Multi-modal Chat Assistant:** Features a built-in AI chat assistant that provides verifiable, descriptive insights of images, free from rigid class labels, serving as an added quality control mechanism.</li>
                    
                    <li>**Versatility for Analog and Telepathology:** Shows compatibility with live microscope camera feeds, including those from personal smartphones, extending its potential application to analog microscopy, intraoperative assessments, and telepathology settings.</li>
                    
                    <li>**Barrier Removal for AI Adoption:** Addresses and removes key obstacles to the widespread adoption of AI tools in histopathology by offering a flexible, secure, and easily deployable solution.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>OnSight Pathology employs a computer vision software that operates by continuously capturing the screen content from any digital slide viewer or live microscope camera feed (including smartphones). It processes these screen captures locally using embedded AI models to generate real-time inferences, which are then presented to the user. The software is distributed as a self-contained executable, requiring no complex integration with existing proprietary systems.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The study successfully demonstrated OnSight Pathology's ability to provide real-time AI inferences across over 2,500 diverse public and clinical whole slide images and different slide viewers. It exhibited robust performance in routine tasks such as brain tumor classification, mitosis detection, and IHC quantification. Furthermore, the platform proved compatible with live microscope camera feeds, including those from smartphones, and incorporated a multi-modal chat assistant for verifiable image descriptions.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>OnSight Pathology has the potential to significantly improve diagnostic efficiency and accuracy in histopathology by providing immediate, AI-driven insights during routine slide review. Its platform-agnostic nature can accelerate AI adoption by bypassing proprietary system lock-ins and complex IT deployments. The compatibility with live microscope feeds could revolutionize intraoperative pathology consultations and telepathology, extending specialist expertise to remote locations and standardizing diagnostic quality globally. The built-in chat assistant also offers an innovative layer of quality control for pathology reports.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state any limitations of the OnSight Pathology platform or the study itself.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The demonstration of compatibility with live microscope camera feeds, including smartphones, suggests future research and development directions focused on expanding deployment in analog, inter-operative, and telepathology settings. Further work could explore integration into diverse global health contexts and the refinement of the multi-modal chat assistant for broader diagnostic support.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Pathology</span>
                    
                    <span class="tag">Oncology</span>
                    
                    <span class="tag">Histology</span>
                    
                    <span class="tag">Diagnostic Medicine</span>
                    
                    <span class="tag">Telemedicine</span>
                    
                    <span class="tag">Neuro-oncology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Computational pathology</span>
                    
                    <span class="tag tag-keyword">Artificial intelligence</span>
                    
                    <span class="tag tag-keyword">Histopathology</span>
                    
                    <span class="tag tag-keyword">Digital pathology</span>
                    
                    <span class="tag tag-keyword">Real-time AI</span>
                    
                    <span class="tag tag-keyword">Platform-agnostic</span>
                    
                    <span class="tag tag-keyword">Whole slide imaging</span>
                    
                    <span class="tag tag-keyword">Telepathology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">The microscopic examination of surgical tissue remains a cornerstone of disease classification but relies on subjective interpretations and access to highly specialized experts, which can compromise accuracy and clinical care. While emerging breakthroughs in artificial intelligence (AI) offer promise for automated histological analysis, the growing number of proprietary digital pathology solutions has created barriers to real-world deployment. To address these challenges, we introduce OnSight Pathology, a platform-agnostic computer vision software that uses continuous custom screen captures to provide real-time AI inferences to users as they review digital slide images. Accessible as a single, self-contained executable file (https://onsightpathology.github.io/ ), OnSight Pathology operates locally on consumer-grade personal computers without complex software integration, enabling cost-effective and secure deployment in research and clinical workflows. Here we demonstrate the utility of OnSight Pathology using over 2,500 publicly available whole slide images across different slide viewers, as well as cases from our clinical digital pathology setup. The software's robustness is highlighted across routine histopathological tasks, including the classification of common brain tumor types, mitosis detection, and the quantification of immunohistochemical stains. A built-in multi-modal chat assistant provides verifiable descriptions of images, free of rigid class labels, for added quality control. Lastly, we show compatibility with live microscope camera feeds, including from personal smartphones, offering potential for deployment in more analog, inter-operative, and telepathology settings. Together, we highlight how OnSight Pathology can deliver real-time AI inferences across a broad range of pathology pipelines, removing key barriers to the adoption of AI tools in histopathology.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>